No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹1,720Prev. Close
₹1,698.5Turnover(Lac.)
₹2,513.81Day's High
₹1,730.7Day's Low
₹1,676.552 Week's High
₹1,83052 Week's Low
₹1,228.9Book Value
₹198.19Face Value
₹10Mkt Cap (₹ Cr.)
32,709.88P/E
42.83EPS
39.66Divi. Yield
01 Aug 2025
12:00 AM
AGM
Announcement Date: 01 Aug, 2025
28 Apr 2026
12:00 AM
Board Meeting
Agenda : Audited Result
22 May 2025
12:00 AM
Dividend
Dividend Amount: 3
Record Date: 14 Aug, 2025
Here are some of the stocks that may see significant price movement today: GAIL (India), Adani Ports and SEZ, Spandana Sphoorty, etc.
Here are some of the stocks that may see significant price movement today: Emcure Pharma, Tata Power, One 97 Communications, etc.
The price stated is a discount of about 7% to Emcure Pharma’s closing price of ₹1,394.10 on the NSE on November 17, 2025.
This is a second brand of Wegovy® (semaglutide injection 2.4 mg), in a move aimed at expanding access to its anti-obesity therapy across the country.
Here are some of the stocks that may see significant price movement today: Tech Mahindra, L&T Technology, Maruti Suzuki, etc.
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 189.48 | 181.15 | 180.85 | 180.85 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2,834.88 | 1,753.95 | 1,661.02 | 1,531.68 |
Net Worth | 3,024.36 | 1,935.1 | 1,841.87 | 1,712.53 |
Minority Interest |
No Record Found
No Record Found
No Record Found
| Particulars (Rupees in Crores.) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
Gross Sales | 9,203.54 | 7,896 | 6,658.25 | 5,985.81 | 5,855.39 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 9,203.54 | 7,896 | 6,658.25 | 5,985.81 | 5,855.39 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 12.66 | 67.26 | 56.99 | 45.91 | 63.47 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,844.3 | 147.48 | 4,42,677.3 | 608.7 | 0.87 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,797.5 | 67.78 | 1,80,457.58 | 756 | 0.44 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,537.8 | 68.47 | 1,53,684.69 | 467 | 0 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,418.2 | 30.96 | 1,14,562.27 | 384.64 | 0.92 | 3,840.92 | 423.38 |
Dr Reddys Laboratories Ltd DRREDDY | 1,319 | 34.19 | 1,10,095.43 | -219.4 | 0.61 | 3,802.6 | 375.78 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole Time Director
MUKUND KESHAO GURJAR
Whole Time Director
SUNIL RAJNIKANT MEHTA
Managing Director & Chief Executive Officer
SATISH RAMANLAL MEHTA
Chairman (Non-Executive)
Berjis M Desai
Whole Time Director
NAMITA VIKAS THAPAR
Independent Director
P S Jayakumar
Independent Director
Vijay Gokhale
Independent Director
Vidya Rajiv Yeravdekar
Independent Director
Shailesh Ayyangar
Whole-time Director
SAMIT SATISH MEHTA
Company Sec. & Compli. Officer
Amruta Jana Yangalwar
Plot # P-1 & P-2 IT BT Park,
Phase II MIDC Hinjawadi,
Maharashtra - 411057
Tel: +91 20 3507 0033/+91 20 3507 0000
Website: http://www.emcure.com
Email: investors@emcure.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited, as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Re...
Read More
Reports by Emcure Pharmaceuticals Ltd
What is the Emcure Pharmaceuticals Ltd share price today?
What is the Market Cap of Emcure Pharmaceuticals Ltd?
What is the PE and PB ratio of Emcure Pharmaceuticals Ltd?
What is the 52 Week High and Low of Emcure Pharmaceuticals Ltd?
What is the CAGR of Emcure Pharmaceuticals Ltd?
What is the shareholding pattern of Emcure Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
